Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Profit After Tax (2019 - 2023)

Historic Profit After Tax for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to -$46.7 million.

  • ADC Therapeutics' Profit After Tax rose 767.07% to -$46.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$95.7 million, marking a year-over-year increase of 2729.84%. This contributed to the annual value of $4.7 billion for FY2022, which is 527.6% up from last year.
  • Per ADC Therapeutics' latest filing, its Profit After Tax stood at -$46.7 million for Q3 2023, which was up 767.07% from -$48.9 million recorded in Q2 2023.
  • ADC Therapeutics' 5-year Profit After Tax high stood at $43.5 million for Q1 2020, and its period low was -$126.6 million during Q2 2020.
  • Moreover, its 5-year median value for Profit After Tax was -$51527.0 (2021), whereas its average is -$19.5 million.
  • Per our database at Business Quant, ADC Therapeutics' Profit After Tax soared by 10002.22% in 2021 and then tumbled by 269695798.07% in 2022.
  • Over the past 5 years, ADC Therapeutics' Profit After Tax (Quarter) stood at -$35285.0 in 2019, then tumbled by 57510.88% to -$20.3 million in 2020, then surged by 99.83% to -$34381.0 in 2021, then grew by 29.74% to -$24157.0 in 2022, then tumbled by 193326.34% to -$46.7 million in 2023.
  • Its Profit After Tax was -$46.7 million in Q3 2023, compared to -$48.9 million in Q2 2023 and -$59426.0 in Q1 2023.